Brooks Laboratories Limited

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

Ask AI

Key metrics

Price as of 2026-04-16

Stock price
₹69.58
Market cap
205 Cr
Stock P/E
10.0
P/B
1.67

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricJun 2023Sept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Sales16 Cr40 Cr62 Cr79 Cr18 Cr39 Cr21 Cr23 Cr26 Cr23 Cr17 Cr20 Cr
Operating expenses (approx.)16 Cr38 Cr59 Cr75 Cr18 Cr37 Cr19 Cr21 Cr22 Cr21 Cr16 Cr19 Cr
EBITDA0.08 Cr2 Cr3 Cr4 Cr0.35 Cr2 Cr2 Cr2 Cr3 Cr3 Cr0.86 Cr1 Cr
OPM %0.5%4.7%5.1%5.2%1.9%5.3%7.8%9.3%13.1%12.4%5.2%5.5%
Other income0.05 Cr0.15 Cr0.30 Cr0.96 Cr0.07 Cr0.27 Cr0.03 Cr0.62 Cr0.22 Cr0.39 Cr0.13 Cr0.44 Cr
Interest0.17 Cr0.36 Cr0.57 Cr0.84 Cr0.16 Cr0.48 Cr0.28 Cr0.26 Cr0.30 Cr0.28 Cr0.16 Cr0.09 Cr
Depreciation0.44 Cr0.88 Cr1 Cr2 Cr0.40 Cr0.83 Cr0.38 Cr0.39 Cr0.39 Cr0.39 Cr0.39 Cr0.41 Cr
Profit before tax-0.53 Cr0.65 Cr1 Cr2 Cr-0.21 Cr0.74 Cr0.94 Cr2 Cr3 Cr2 Cr0.30 Cr0.61 Cr
Tax %0.0%0.0%2.1%1.7%0.0%0.0%0.0%11.6%0.0%0.0%0.0%0.0%
Net profit-4 Cr-6 Cr-10 Cr-20 Cr-2 Cr-6 Cr-2 Cr-1 Cr10 Cr8 Cr5 Cr2 Cr
EPS (₹)₹-1.75₹-2.38₹-3.90₹-7.67₹-0.94₹-2.43₹-0.82₹-0.54₹3.25₹2.71₹1.87₹0.52

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2021Standalone onlyMar 2022Standalone onlyMar 2023Mar 2024Mar 2025Mar 2026TTM
Sales77 Cr91 Cr63 Cr79 Cr83 Cr86 CrSign in for TTM
Operating expenses (approx.)76 Cr105 Cr90 Cr11,137 Cr77 Cr78 CrSign in for TTM
EBITDA1 Cr-13 Cr-27 Cr-11,058 Cr6 Cr8 CrSign in for TTM
OPM %1.6%-14.8%-42.4%-13911.5%7.1%9.6%Sign in for TTM
Other income0.74 Cr0.91 Cr0.20 Cr95,555 Cr0.88 Cr1 CrSign in for TTM
Interest3 Cr3 Cr2 Cr84,494 Cr1 Cr0.84 CrSign in for TTM
Depreciation7 Cr7 Cr7 Cr2 Cr2 Cr2 CrSign in for TTM
Profit before tax-9 Cr-24 Cr-36 Cr2 Cr3 Cr6 CrSign in for TTM
Tax %-115.5%19.2%20.5%166800.7%5.5%0.0%Sign in for TTM
Net profit-19 Cr-19 Cr-32 Cr-20 Cr-10 Cr25 CrSign in for TTM
EPS (₹)₹6.31₹-7.82₹-12.57₹-7.67₹-3.72₹8.35Sign in for TTM
Dividend payout %—0.0%———0.0%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2021Standalone onlyMar 2022Standalone onlyMar 2023Mar 2024Mar 2025Mar 2026
Equity capital25 Cr25 Cr25 Cr26 Cr29 Cr29 Cr
Reserves0.0000 Cr54 Cr63 Cr49 Cr69 Cr93 Cr
Borrowings8 Cr5 Cr6 Cr5 Cr6 Cr6 Cr
Other liabilities21 Cr34 Cr30 Cr20 Cr20 Cr19 Cr
Total liabilities93 Cr103 Cr110 Cr90 Cr124 Cr148 Cr
Fixed assets (net)14 Cr14 Cr14 Cr13 Cr13 Cr13 Cr
CWIP0.02 Cr1 Cr0.0000 Cr0.0000 Cr1 Cr1 Cr
Investments0.0000 Cr0.0000 Cr0.0000 Cr43 Cr74 Cr92 Cr
Other assets26 Cr37 Cr2,353 Cr12,572 Cr34 Cr37 Cr
Total assets93 Cr103 Cr110 Cr90 Cr124 Cr148 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2021Standalone onlyMar 2022Standalone onlyMar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity—-37 Cr-14 Cr-10 Cr3 Cr9 Cr
Cash from investing—-25 Cr0.49 Cr18,219 Cr-46 Cr-3 Cr
Cash from financing—64 Cr11 Cr10 Cr43 Cr0.17 Cr
Net cash flow—2 Cr-3 Cr18,219 Cr-0.08 Cr7 Cr
Free cash flow (OCF − Capex)—-65 Cr-15 Cr-43,907 Cr2 Cr6 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2021Standalone onlyMar 2022Standalone onlyMar 2023Mar 2024Mar 2025Mar 2026
ROCE %-23.8%-26.3%-42.5%-15658.9%4.1%5.2%
ROE %-78.4%-20.5%-28.3%-29.9%-10.2%20.0%
Debtor days45717375——
Inventory days9713099787181
Days payable105202205126——
Cash conversion cycle37-1-32277181
Debt / equity0.130.080.080.080.060.05
Current ratio0.981.040.841.351.481.72
Net debt / EBITDA0.002.58——1.01-0.06

Compare with peers

Loading peers…